CNCR vs. GERM

Last updated Apr 2, 2026

Compare and contrast key facts about Loncar Cancer Immunotherapy ETF (CNCR) and Amplify Treatments, Testing and Advancements ETF (GERM).

CNCR and GERM are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. CNCR is a passively managed fund by Exchange Traded Concepts that tracks the performance of the Loncar Cancer Immunotherapy Index. It was launched on Oct 13, 2015. GERM is a passively managed fund by Amplify that tracks the performance of the Prime Treatments, Testing and Advancements Index. It was launched on Jun 17, 2020. Both CNCR and GERM are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.

Performance

CNCR vs. GERM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Loncar Cancer Immunotherapy ETF (CNCR) and Amplify Treatments, Testing and Advancements ETF (GERM). The values are adjusted to include any dividend payments, if applicable.

CNCR vs. GERM - Yearly Performance Comparison

	2026 (YTD)
CNCR Loncar Cancer Immunotherapy ETF	0.00%
GERM Amplify Treatments, Testing and Advancements ETF	0.00%

Returns By Period

CNCR

• 1D: 0.00%
• 1M: 0.00%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

GERM

• 1D: 0.00%
• 1M: 0.00%
• YTD: 0.00%
• 6M: 0.00%
• 1Y: 0.00%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

CNCR vs. GERM - Expense Ratio Comparison

CNCR has a 0.79% expense ratio, which is higher than GERM's 0.68% expense ratio.

CNCR

Loncar Cancer Immunotherapy ETF

GERM

Amplify Treatments, Testing and Advancements ETF

Return for Risk

CNCR vs. GERM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Loncar Cancer Immunotherapy ETF (CNCR) and Amplify Treatments, Testing and Advancements ETF (GERM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Dividends

CNCR vs. GERM - Dividend Comparison

Neither CNCR nor GERM has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

CNCR vs. GERM - Drawdown Comparison

The maximum CNCR drawdown since its inception was 0.00%, which is greater than GERM's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for CNCR and GERM.

Drawdown Indicators

	CNCR	GERM	Difference
Max Drawdown Largest peak-to-trough decline	0.00%	0.00%	0.00%
Max Drawdown (1Y) Largest decline over 1 year	—	0.00%	—
Current Drawdown Current decline from peak	0.00%	0.00%	0.00%
Average Drawdown Average peak-to-trough decline	0.00%	0.00%	0.00%
Ulcer Index Depth and duration of drawdowns from previous peaks	—	0.00%	—

Volatility

Volatility by Period

	CNCR	GERM	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	0.00%	—
Volatility (6M) Calculated over the trailing 6-month period	—	0.00%	—
Volatility (1Y) Calculated over the trailing 1-year period	0.00%	0.00%	0.00%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	0.00%	0.00%	0.00%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	0.00%	0.00%	0.00%